Total Payments
$843.80
2024 Payments
$340.30
Companies
17
Transactions
34
Medicare Patients
4,597
Medicare Billing
$727,699
Payment Breakdown by Category
Food & Beverage$843.80 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $843.80 | 34 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UROVANT SCIENCES INC | $124.59 | 1 | $0 (2022) |
| Novo Nordisk Inc | $120.78 | 7 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $96.05 | 1 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $88.18 | 5 | $0 (2024) |
| UCB, Inc. | $71.31 | 3 | $0 (2024) |
| Daiichi Sankyo Inc. | $60.04 | 3 | $0 (2024) |
| Inspire Medical Systems, Inc. | $46.46 | 2 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $39.40 | 2 | $0 (2020) |
| Neurelis, Inc. | $36.89 | 2 | $0 (2023) |
| Avanir Pharmaceuticals, Inc. | $23.68 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $340.30 | 17 | Novo Nordisk Inc ($84.02) |
| 2023 | $282.35 | 11 | ACADIA Pharmaceuticals Inc ($96.05) |
| 2022 | $158.07 | 3 | UROVANT SCIENCES INC ($124.59) |
| 2020 | $43.29 | 2 | Avanir Pharmaceuticals, Inc. ($23.68) |
| 2019 | $19.79 | 1 | Merck Sharp & Dohme Corporation ($19.79) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/23/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Neurology | ||||||
| 10/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Obesity | ||||||
| 09/25/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $30.68 | General |
| Category: Neurology | ||||||
| 09/20/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/04/2024 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: HEMATOLOGY | ||||||
| 08/14/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Neurology | ||||||
| 08/06/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Diabetes | ||||||
| 07/22/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Iron Deficiency Anemia | ||||||
| 07/16/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: Oncology | ||||||
| 06/26/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: Diabetes | ||||||
| 05/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Obesity | ||||||
| 04/18/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: NEUROLOGY | ||||||
| 03/21/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/06/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: NEUROLOGY | ||||||
| 01/17/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Iron Deficiency Anemia | ||||||
| 01/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Obesity | ||||||
| 11/27/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $96.05 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/20/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Iron Deficiency Anemia | ||||||
| 09/20/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/06/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Obesity | ||||||
| 07/12/2023 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: EPILEPSY | ||||||
| 06/29/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.38 | General |
| Category: PSYCHIATRY | ||||||
| 06/27/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/14/2023 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: EPILEPSY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 2,150 | 5,829 | $845,736 | $397,857 |
| 2022 | 42 | 2,119 | 3,670 | $509,374 | $231,233 |
| 2021 | 9 | 230 | 601 | $95,164 | $48,925 |
| 2020 | 3 | 98 | 570 | $86,240 | $49,684 |
Total Patients
4,597
Total Services
10,670
Medicare Billing
$727,699
Procedure Codes
87
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 202 | 2,834 | $425,100 | $193,502 | 45.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 274 | 882 | $132,300 | $63,249 | 47.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 216 | 313 | $61,015 | $35,533 | 58.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 172 | 183 | $54,900 | $28,254 | 51.5% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 128 | 135 | $33,750 | $22,293 | 66.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 97 | 101 | $25,250 | $7,468 | 29.6% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 21 | 108 | $16,200 | $7,404 | 45.7% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2023 | 54 | 54 | $10,800 | $6,470 | 59.9% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 39 | 67 | $15,075 | $5,207 | 34.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 26 | $7,225 | $4,295 | 59.4% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 88 | 94 | $12,220 | $3,254 | 26.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 19 | 19 | $3,515 | $2,831 | 80.5% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 17 | 24 | $4,200 | $2,790 | 66.4% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 70 | 144 | $3,600 | $2,336 | 64.9% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2023 | 38 | 41 | $3,075 | $1,577 | 51.3% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2023 | 13 | 13 | $2,275 | $1,220 | 53.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 11 | $1,925 | $1,195 | 62.1% |
| 82306 | Vitamin d-3 level | Office | 2023 | 27 | 32 | $3,200 | $928.32 | 29.0% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 53 | 55 | $1,375 | $891.00 | 64.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 82 | 100 | $1,200 | $840.00 | 70.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 43 | 51 | $4,590 | $839.46 | 18.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 67 | 81 | $3,159 | $838.35 | 26.5% |
| 84480 | Thyroid hormone, t3 measurement, total | Office | 2023 | 44 | 51 | $2,550 | $708.90 | 27.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 76 | 93 | $2,325 | $707.73 | 30.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 50 | 61 | $3,172 | $580.72 | 18.3% |
About Solaiman Chowdhury
Solaiman Chowdhury is a Internal Medicine healthcare provider based in East Islip, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2016. The National Provider Identifier (NPI) number assigned to this provider is 1053763458.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Solaiman Chowdhury has received a total of $843.80 in payments from pharmaceutical and medical device companies, with $340.30 received in 2024. These payments were reported across 34 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($843.80).
As a Medicare-enrolled provider, Chowdhury has provided services to 4,597 Medicare beneficiaries, totaling 10,670 services with total Medicare billing of $727,699. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location East Islip, NY
- Active Since 07/08/2016
- Last Updated 05/04/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1053763458
Products in Payments
- GEMTESA (Drug) $124.59
- NUPLAZID (Drug) $96.05
- Wegovy (Drug) $81.46
- Briviact (Drug) $71.31
- LOKELMA (Drug) $70.74
- INJECTAFER (Drug) $60.04
- INSPIRE (Device) $46.46
- ISENTRESS (Drug) $39.40
- Rybelsus (Drug) $39.32
- VALTOCO (Drug) $36.89
- NUEDEXTA (Drug) $23.68
- OXBRYTA (Drug) $21.36
- TZIELD (Biological) $21.23
- ACTIMMUNE (Drug) $20.35
- Cologuard Collection Kit (Device) $20.28
- ENTRESTO (Drug) $19.46
- REXULTI (Drug) $18.38
- FARXIGA (Drug) $17.44
- SHINGRIX (Biological) $15.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.